Barclays’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,668
| Closed | -$1K | – | 4495 |
|
|
2024
Q2 | $1K | Hold |
2,668
| – | – | ﹤0.01% | 4162 |
|
|
2024
Q1 | $3K | Hold |
2,668
| – | – | ﹤0.01% | 4090 |
|
|
2023
Q4 | $2K | Hold |
2,668
| – | – | ﹤0.01% | 4143 |
|
|
2023
Q3 | $3K | Hold |
2,668
| – | – | ﹤0.01% | 4163 |
|
|
2023
Q2 | $4K | Hold |
2,668
| – | – | ﹤0.01% | 4131 |
|
|
2023
Q1 | $4K | Sell |
2,668
-83
| -3% | -$124 | ﹤0.01% | 4189 |
|
|
2022
Q4 | $4K | Sell |
2,751
-2,093
| -43% | -$3.04K | ﹤0.01% | 4238 |
|
|
2022
Q3 | $20K | Buy |
4,844
+2,176
| +82% | +$8.98K | ﹤0.01% | 3947 |
|
|
2022
Q2 | $10K | Sell |
2,668
-5,886
| -69% | -$22.1K | ﹤0.01% | 4333 |
|
|
2022
Q1 | $41K | Buy |
+8,554
| New | +$41K | ﹤0.01% | 4084 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4427 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4425 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4027 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4089 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3905 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3712 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3827 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4144 |
|
|
2015
Q2 | – | Sell |
-413
| Closed | -$173K | – | 4235 |
|
|
2015
Q1 | $173K | Buy |
413
+394
| +2,074% | +$165K | ﹤0.01% | 2319 |
|
|
2014
Q4 | $8K | Sell |
19
-373
| -95% | -$157K | ﹤0.01% | 3830 |
|
|
2014
Q3 | $577K | Buy |
392
+163
| +71% | +$240K | ﹤0.01% | 1905 |
|
|
2014
Q2 | $289K | Sell |
229
-182
| -44% | -$230K | ﹤0.01% | 2227 |
|
|
2014
Q1 | $519K | Buy |
411
+199
| +94% | +$251K | ﹤0.01% | 1978 |
|
|
2013
Q4 | $179K | Buy |
212
+206
| +3,433% | +$174K | ﹤0.01% | 2707 |
|
|
2013
Q3 | $5K | Sell |
6
-71
| -92% | -$59.2K | ﹤0.01% | 3805 |
|
|
2013
Q2 | $84K | Buy |
+77
| New | +$84K | ﹤0.01% | 3114 |
|